V. Cherkasov et al. / Tetrahedron 67 (2011) 80e84
83
1Harom, J¼2.2); 7.67 (s, 1H, OH). 13C NMR (CDCl3,
d
/ppm): 29.5 and
1265m, 1240s, 1210m, 1200m, 1165s, 1130w, 1100w, 1020s, 1000s,
965m, 935w, 915w, 865m, 855w, 840w, 820w, 795w, 750w, 740w,
31.7(C(CH3)3); 34.6 and 35.0 (C(CH3)3); 53.1 (CH (NeCH2)); 67.8 (CH
(OeCH2)); 115.6 and 120.9 (CH, C(3 and 5)); 134.4 and 141.3 (C-t-
Bu); 138.0 (CeNeCH2); 147.7 (CeP).
720s, 655w. 1H NMR (CDCl3,
d/ppm, J/Hz): 1.32,1.33,1.34, and 1.35 (all
s,9H, t-Bu); 2.97 (s, 3H, CH3);6.53 and6.77 (bothd, C (40), (60)H, J¼1.9);
6.88e6.90 (AB, 2H, C (5), (7)H, J¼1.9). 13C NMR (CDCl3,
d/ppm): 27.0
4.2.5. 2-(4-Phenylpiperazin-1-yl)-4,6-di-tert-butylphenol
(4c). Colorless crystals, yield: 1.90 g (52%); mp¼112 ꢀC. Found (%):
C, 78.60; H, 9.36. Calculated for C24H34N2O (%): C, 78.64; H, 9.35. IR
(NCH3); 29.5, 29.7, 31.9, 32.0 (C(CH3)3); 34.1, 34.3, 35.0, 35.1(C(CH3)3);
101.0 (CH); 103.9 (CH); 113.4 (CH); 115.6 (CH); 130.8 (C); 131.6 (C);
134.9 (C); 136.3 (C); 140.1 (C); 140.5 (C); 144.8 (C); 145.1 (C); 145.2 (C).
The crystals of 7 (CCDC 772231) suitable for X-ray were obtained from
CH3CN. Crystal data: C30H43NO3, M¼465.65, monoclinic, space group
P2(1)/c, Z¼4 in a cell of dimensions: a¼9.9571(5ꢀ ), b¼22.3032(12),
(Nujol,
n
/cmꢁ1): 3250 br, 1610s, 1510m, 1500m, 1425s, 1400m,
1385m, 1370m, 1325m, 1295w, 1250s, 1240s, 1210m, 1160w, 1145m,
1105w, 1065w, 990m, 985s, 920m, 875w, 820w, 790w, 765s, 690m,
650w, 635w, 520w. 1H NMR (CDCl3,
d/ppm): 1.30 and 1.42 (both s,
c¼13.0620(7) A,
a
¼90ꢀ,
b
¼109.7810(10)ꢀ,
g
¼90 , V¼2729.6(2) A ,
3
ꢀ
ꢀ
9H, t-Bu); 3.03e3.07 (m, 4H, CeNeCH2); 3.36 (m, 4H, CH2eNePh);
6.89e6.99 (m, 4H, m-, p-Ph, H(5)); 7.26e7.35 (m, 2H, o-Ph); 7.69 (s,
T¼130(2) L,
m
¼0.072 mmꢁ1, dcal¼1.133 g/cm3, 23421 reflections were
measured, 5352 unique (Rint¼0.0375), which were used in all calcu-
1H, OH). 13C NMR (CDCl3,
d/ppm): 29.5 and 31.7 (C(CH3)3); 34.6 and
lations. R1[I>2
s
(I)]¼0.0502, wR2¼0.1251, GOF(F2)¼1.036.
35.0 (C(CH3)3); 50.4 and 52.8 (NeCH2); 115.6; 116.5; 120.2; 120.9;
129.2; 134.3; 138.1; 141.3; 147.7; 151.3.
4.3.2. 4,50,7,70-Tetra-tert-butyl-30-methyl-30H-spiro[1,3-benzodioxol-
2,20-[1,3]benzoxazole] (9). Colorless microcrystalline powder, yield:
3.73 g (80%); mp¼187e188 ꢀC. Found (%): C, 77.41; H, 9.30. Calculated
4.2.6. 2-(N-Diphenylmethyl-piperazin-1-yl)-4,6-di-tert-butylphenol
(4d). Colorless crystals, yield: 2.74 g (60%); mp¼155e156 ꢀC. Found
(%): C, 81.53; H, 8.83. Calculated for C31H40N2O (%): C, 81.49; H, 8.85.
for C30H43NO3 (%): C, 77.38; H, 9.31. IR (Nujol, n
/cmꢁ1): 1620m, 1510m,
1490s, 1425s, 1400m, 1370s, 1310s, 1265m, 1245s, 1210m, 1155s,
1130m, 1030s, 1000s, 970m, 890w, 845w, 810m, 795m, 740m, 655w,
IR (Nujol, n
/cmꢁ1): 3230 br, 1610w, 1430m, 1395m, 1365s, 1350m,
1340m, 1315m, 1285s, 1270m, 1255s, 1225m, 1210m, 1185w, 1170w,
1135s, 1080m, 1010m, 990s, 960m, 930m, 880w, 850m, 820w,
785w, 770m, 755s, 750m, 700s, 695s, 650m, 630w, 590w, 520w. 1H
640w. 1H NMR (CDCl3,
d/ppm, J/Hz): 1.33 and 1.34 (both s, 9H, t-Bu);
1.36 (s,18H, t-Bu); 2.99 (s, 3H, CH3); 6.56 and 6.78 (both d, C (40), (60)H,
J¼1.8); 6.83 (s, 2H, C (5), (6)H). 13C NMR (CDCl3,
d/ppm): 27.5 (NCH3);
NMR (CDCl3,
d/ppm, J/Hz): 1.31 and 1.41 (both s, 18H, t-Bu); 2.58 (br
29.3 (C (4), (7), C(CH3)3); 29.4 and 31.9 (C (50), (70), C(CH3)3); 33.7, 34.0,
34.9(C(CH3)3); 100.9(CH);113.2 (CH);118.3 (CH);130.3(C);130.6(C);
134.7 (C); 135.5 (C); 140.0 (C); 142.7 (C); 145.0 (C).
m, 4H, CH2NCH); 2.91 (m, 4H, CH2NC); 4.32 (s, 1H, NCHPh2);
7.147.48 (m, 10H (Ph) and 2Harom); 7.77 (br s, 1H, OH). 13C NMR,
DEPT (CDCl3, d/ppm): 29.5 and 31.7 (C(CH3)3); 34.6 and 34.9 (C
(CH3)3); 52.9 and 53.1 (NCH2); 115.8 and 120.7 (CH, C(3 and 5));
127.1 (CH, p-Ph); 128.0 and 128.6 (CH, o-, m-Ph); 134.0 and 141.0 (C-
t-Bu); 138.3 (CeN); 142.6 (CHPh2); 147.8 (CeP).
4.3.3. N-(3,5-Di-tert-butyl-2-hydroxyphenyl)-N-methylformamide
(7). p-Aminophenol 2 (2.5 g, 0.01 mol) was dissolved in ether
(40 mL) and PbO2 was added (4.8 g, 0.02 mol). The reaction mixture
was stirred at 20 ꢀC for 1 h and then filtered. The ether was evap-
orated and residue was separated by column chromatography
(silicagel ‘Acros’ 0.060e0.200 mm; eluent hexane/ethylacetate is
50:1). Two products were isolated.
4.2.7. 6,6’-(Piperazine-1,4-diyl)bis(2,4-di-tert-butylphenol)
(5). Colorless crystals, yield: 1.53 g (62%); mp¼287e288 ꢀC. Found
(%): C, 77.70; H, 10.21. Calculated for C32H50N2O2 (%): C, 77.68; H,
10.19. IR (Nujol,
n
/cmꢁ1): 3250 br, 1615w, 1425s, 1400m, 1365m,
From the first fraction 5,7-di-tert-butyl-3-methyl-2,3-dihy-
1325m, 1285m, 1270m, 1245s, 1220m, 1200m, 1160m, 1130m,
1120m, 1075m, 950w, 895w, 870w, 845w, 815m, 790w, 765m,
drobenzo[d]oxazole (8)was extracted. 1H NMR (CDCl3,
d/ppm, J/Hz):
1.30 and 1.35 (both s, 9H, t-Bu); 2.74 (s, 3H, CH3); 5.17 (s, 2H, CH2);
740w, 680m, 410w. 1H NMR (CDCl3,
d
/ppm, J/Hz): 1.33 and 1.43
6.51 and 6.70 (both d,1Harom, J¼1.8). 13C NMR, DEPT (CDCl3,
d/ppm):
(both s, 18H, t-Bu); 3.07 (m, 8H, CH2), 7.15 and 7.18 (both d, 1Harom
,
29.7 and 31.9 (C(CH3)3); 34.2 and 34.9 (C(CH3)3); 35.2 (NCH3); 90.8
(CH2); 104.2 (CH); 114.4 (CH); 131.1 (C); 140.6 (C); 144.2 (C); 146.5
(C). After adding excess of PbO2 to the solution of dihydrobenzox-
azole 8 in ether its quantitative gives N-methylformamide 7.
Then the second fraction was collected and the eluent was
evaporated and residue was crystallized in ether. After being fil-
tered colorless crystals of 7 washed with cold pentane and dried
(mp¼173e174 ꢀC.) Found (%): C, 73.00; H, 9.55. Calculated for
J¼2.3); 7.69 (br s, 1H, OH). 13C NMR, DEPT (CDCl3,
d/ppm): 29.5 and
31.7 (C(CH3)3); 34.6 and 35.0 (C(CH3)3); 53.6 (CH2); 115.5 and 120.9
(CH, C(3 and 5)); 134.3 and 141.2 (C-t-Bu); 138.1 (CeN); 147.7
(CeP). The crystals of 6 (CCDC-772232) suitable for X-ray structure
determination were obtained by recrystallization from MeOH.
Crystal data: C32H50N2O2, M¼494.74, monoclinic, space group C2/C,
Z¼4 in a cell of dimensions: a¼17.2309(1), b¼8.8066(7), c¼19.4719
3
(1) A,
m
a
¼90ꢀ,
b
¼94.511(2)ꢀ,
g
¼90 , V¼2945.6(4) A , T¼100(2) L,
C16H25NO2 (%): C, 72.96; H, 9.57. IR (Nujol, n
/cmꢁ1): 3320s, 1670s,
ꢀ
ꢀ
ꢀ
¼0.068 mmꢁ1, dcal¼1.116 g/cm3, 9618 reflections were measured,
1590m, 1270w, 1250s, 1210m, 1185m, 1140w, 1120w, 1035m,
1020w, 920w, 875w, 825w, 810w, 775w, 745w, 720m, 660w, 640w.
3373 unique (Rint¼0.0249), which were used in all calculations.
R1[I>2
s
(I)]¼0.0438, wR2¼0.1181, GOF(F2)¼1.030.
1H NMR (CDCl3,
d/ppm, J/Hz) isomer 1: 1.29 and 1.43 (both s, 9H, t-
Bu); 3.21 (s, 3H, CH3); 5.92 (br s, 1H, OH); 6.92 and 7.33 (both d,
1Harom, J¼1.8); 8.18 (s, 1H, HeC]O). Isomer 2: 1.29 and 1.43 (both
s, 9H, t-Bu); 3.45 (s, 3H, CH3); 6.67 (s, 1H, OH); 7.00 and 7.29 (both
d, 1Harom, J¼1.8); 8.31 (s, 1H, HeC]O). Ratio of isomers 2:1. 13C
4.3. General procedure for preparation of spirocompounds 6
and 9
A solution of p-aminophenol 2 (2.5 g; 0.01 mol) and three-fold
excess of 3,5- or 3,6-di-tert-butyl-o-benzoquinone (6.6 g; 0.03 mol)
in benzene (50 mL) was refluxed until o-quinone color disappeared.
Benzene was replaced by CH3CN. The resulting solution was filtered
off. Upon cooling colorless crystals are formed.
NMR, DEPT (CDCl3, d/ppm): 29.6 and 31.5 (C(CH3)3); 29.9 (NCH3);
34.3 and 35.3 (C(CH3)3); 122.4 (CH); 124.5 (CH); 128.4 (C); 137.6
(C); 142.8 (C); 148.8 (C); 164.6 (CH). Event of the barrier to internal
rotation about the NeCO bond was discussed.10 The crystals of 7
(CCDC 772230) suitable for X-ray structure determination were
obtained from ether. There is one independent molecule of 7 in
the unit cell. Disorders in molecule of 7 are absent. Therefore, only
one type of rotamers exists in crystal of 7. Crystal data: C16H25NO2,
4.3.1. 4,50,6,70-Tetra-tert-butyl-30-methyl-30H-spiro[1,3-benzodioxol-
2,20-[1,3]benzoxazole] (6). Colorless crystals, yield: 3.54 g (76%);
mp¼159 ꢀC. Found (%): C, 77.40; H, 9.35. Calculated for C30H43NO3 (%):
M¼263.37, triclinic, space group Pꢁ1, Z¼2 in a cell of dimensions:
/cmꢁ1):1615s,1420s,1310s,1290m,1275m,
a¼6.0017(7), b¼9.7281(11), c¼14.3535(16) A,
a
¼70.565(2)ꢀ,
ꢀ
C,77.38;H, 9.31.IR(Nujol,
n